Skip to main content

Animations

MJFF Publications

7241 - 7250 of 9038 Results
Title
Year
  • Year
  • 2023
  • 2022
  • 2022
  • 2023
  • 2023
  • 2023
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29288
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy–Richardson Syndrome
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29299
    Citation Count: 11
  • Implications of DNA Methylation in Lewy Body Pathology
    2022
    Summary Details
    RESTRICTED
    Title: Implications of DNA Methylation in Lewy Body Pathology
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29290
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Susceptibility Magnetic Resonance Imaging Correlates with Glial Density and Tau in the Substantia Nigra Pars Compacta
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29311
    Citation Count: 14
  • Summary Details
    OPEN
    Title: In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29315
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29349
    Citation Count: 19
  • Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future Studies
    2021
    Summary Details
    RESTRICTED
    Title: Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future Studies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28637
    Citation Count: 8
  • Summary Details
    OPEN
    Title: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28639
    Citation Count: 104
  • Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”
    2021
    Summary Details
    RESTRICTED
    Title: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28678
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Multimodal Longitudinal Neurophysiological Investigations in Dopa‐Responsive Dystonia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28679
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.